Amy Dai is a Shanghai-based partner with Global Law Office. Amy Dai has rich experience providing legal services for fund formation and PE/VC investment. She has advised on more than 30 fund formation projects, including pure RMB Fund, JV Fund and USD Fund.  She has also helped many domestic and international funds to invest in China through various structures across industrials such as life science, medical and pharmaceutical, health care, telecommunications, new energy, semi-conductor etc.  In addition, Amy Dai has helped several issuers in their initial public offering on both the international stock exchanges such as Nasdaq, AIM, Hong Kong Stock Exchange, and Taiwan stock exchange. Amy Dai worked for Boehringer Ingelheim (China), a top fifteen multinational pharmaceutical company, as the legal counsel in 2009 and 2010.

Ms. Dai was admitted in the PRC in 2008.  Amy Dai joined Global Law Office in 2009. Prior to joining Global, Amy Dai worked with AllBright Law Offices as an associate.

Admitted in the PRC

2004-2007 Law School, Peking University

2000-2004 Journalism School, Fudan University